Determinants of Vaccine Immunity in the Cohort of Human Immunodeficiency Virus-infected Children Living in Switzerland

被引:10
作者
Myers, Catherine [1 ,2 ]
Posfay-Barbe, Klara M. [1 ,2 ]
Aebi, Christoph [3 ,4 ]
Cheseaux, Jean-Jacques [5 ]
Kind, Christian [6 ]
Rudin, Christoph [7 ]
Nadal, David [8 ]
Siegrist, Claire-Anne [1 ,2 ]
机构
[1] Univ Hosp Geneva, Geneva, Switzerland
[2] Geneva Sch Med, Dept Pediat, Geneva, Switzerland
[3] Univ Bern, Dept Pediat, CH-3012 Bern, Switzerland
[4] Univ Bern, Inst Infect Dis, CH-3012 Bern, Switzerland
[5] CHUV, Univ Hosp, Dept Pediat, Lausanne, Switzerland
[6] Ostschweizer Sauglings & Kinderspital, CH-9007 St Gallen, Switzerland
[7] Univ Childrens Hosp, Basel, Switzerland
[8] Univ Childrens Hosp Zurich, Div Infect Dis & Hosp Epidemiol, Zurich, Switzerland
基金
瑞士国家科学基金会;
关键词
HIV-1; vaccination; immunity; vaccine-preventable diseases; vaccine antibodies; ACTIVE ANTIRETROVIRAL THERAPY; HEPATITIS-B-VIRUS; HIV-1-INFECTED CHILDREN; HIV-1; INFECTION; SEROLOGICAL RESPONSE; PROTECTIVE ANTIBODY; ZAMBIAN CHILDREN; TYPE-1; RISK-FACTOR; T-CELLS;
D O I
10.1097/INF.0b013e3181a78348
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: Human immunodeficiency virus (HIV)-infected children are at increased risk of infections caused by vaccine preventable pathogens, and specific immunization recommendations have been issued. Methods: A prospective national multicenter study assessed how these recommendations are followed in Switzerland and how immunization history correlates with vaccine immunity. Results: Among 87 HIV-infected children (mean age: 11.1 years) followed in the 5 Swiss university hospitals and 1 regional hospital, most (76%) had CD4(+) T cells >25%, were receiving highly active antiretroviral treatment (79%) and had undetectable viral load (60%). Immunization coverage was lower than in the general population and many lacked serum antibodies to vaccine-preventable pathogens, including measles (54%), varicella (39%), and hepatitis B (65%). The presence of vaccine antibodies correlated most significantly with having an up-to-date immunization history (P < 0.05). An up-to-date immunization history was not related to age, immunologic stage, or viremia but to the referral medical center. Conclusions: All pediatricians in charge of HIV-infected children are urged to identify missing immunizations in this high-risk population.
引用
收藏
页码:996 / 1001
页数:6
相关论文
共 45 条
[1]   Immunogenicity, safety, and predictors of response after a pneumococcal conjugate and pneumococcal polysaccharide vaccine series in human immunodeficiency virus-infected children receiving highly active antiretroviral therapy [J].
Abzug, Mark J. ;
Pelton, Stephen I. ;
Song, Lin-Ye ;
Fenton, Terence ;
Levin, Myron J. ;
Nachman, Sharon A. ;
Borkowsky, William ;
Rosenblatt, Howard M. ;
Marcinak, John F. ;
Dieudonne, Arry ;
Abrams, Elaine J. ;
Pathak, Indu .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2006, 25 (10) :920-929
[2]  
Arpadi SM, 1996, PEDIATRICS, V97, P653
[3]   Prevalence of protective antibody against measles in HIV-infected children with immune recovery after highly active antiretroviral therapy [J].
Aurpibul, L. ;
Puthanakit, T. ;
Siriaksorn, S. ;
Sirisanthana, T. ;
Sirisanthana, V. .
HIV MEDICINE, 2006, 7 (07) :467-470
[4]   Persistent humoral immune defect in highly active antiretroviral therapy-treated children with HIV-1 infection: Loss of specific antibodies against attenuated vaccine strains and natural viral infection [J].
Bekker, Vincent ;
Scherpbier, Henriette ;
Pajkrt, Dasja ;
Jurriaans, Suzanne ;
Zaaijer, Hans ;
Kuijpers, Taco W. .
PEDIATRICS, 2006, 118 (02) :E315-E322
[5]   Varicella vaccination in HIV-1-infected children after immune reconstitution [J].
Bekker, Vincent ;
Westerlaken, Geertje H. A. ;
Scherpbier, Henriette ;
Alders, Sophie ;
Zaaijer, Hans ;
van Baarle, Debbie ;
Kuijper, Taco .
AIDS, 2006, 20 (18) :2321-2329
[6]   Effect of highly active antiretroviral therapy on the serological response to additional measles vaccinations in human immunodeficiency virus-infected children [J].
Berkelhamer, S ;
Borock, E ;
Elsen, C ;
Englund, J ;
Johnson, D .
CLINICAL INFECTIOUS DISEASES, 2001, 32 (07) :1090-1094
[7]   Tetanus and diphtheria antibodies and response to a booster dose in Brazilian HIV-1-infected women [J].
Bonetti, TCS ;
Succi, RCM ;
Weckx, LY ;
Tavares-Lopes, L ;
de Moraes-Pinto, MI .
VACCINE, 2004, 22 (27-28) :3707-3712
[8]   CELL-MEDIATED AND HUMORAL IMMUNE-RESPONSES IN CHILDREN INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS DURING THE 1ST 4 YEARS OF LIFE [J].
BORKOWSKY, W ;
RIGAUD, M ;
KRASINSKI, K ;
MOORE, T ;
LAWRENCE, R ;
POLLACK, H .
JOURNAL OF PEDIATRICS, 1992, 120 (03) :371-375
[9]   ANTIBODY-RESPONSES TO BACTERIAL TOXOIDS IN CHILDREN INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS [J].
BORKOWSKY, W ;
STEELE, CJ ;
GRUBMAN, S ;
MOORE, T ;
LARUSSA, P ;
KRASINSKI, K .
JOURNAL OF PEDIATRICS, 1987, 110 (04) :563-566
[10]  
CALDWELL MB, 1994, MMWR-MORBID MORTAL W, V43, P1